Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Salmeterol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 19/20 | 0.81 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.81 |
| ▸ | MEN1 | O00255 | 2/20 | 0.81 |
| ▸ | TP53 | P04637 | 2/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.81 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.81 |
| ▸ | GMNN | O75496 | 1/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.81 |
| ▸ | LMNA | P02545 | 1/20 | 0.81 |
| ▸ | HPGD | P15428 | 1/20 | 0.81 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.81 |
| ▸ | THPO | P40225 | 1/20 | 0.81 |
| ▸ | MTOR | P42345 | 1/20 | 0.81 |
| ▸ | RAB9A | P51151 | 1/20 | 0.81 |
| ▸ | BLM | P54132 | 1/20 | 0.81 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.81 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.81 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.81 |
| ▸ | ADRB1 | P08588 | 18/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Salmeterol SCHEMBL2833182 | 0.90 | ADRB2 (1.00) | ADRB2KDM4EMEN1TP53CYP3A4 | |
| Salmeterol SCHEMBL29372524 | 0.90 | ADRB2 (1.00) | ADRB2KDM4EMEN1TP53CYP3A4 | |
| Salmeterol SCHEMBL29352164 | 0.90 | ADRB2 (1.00) | ADRB2KDM4EMEN1TP53CYP3A4 | |
| Salmeterol SCHEMBL9806070 | 0.90 | ADRB2 (1.00) | ADRB2KDM4EMEN1TP53CYP3A4 | |
| Salmeterol SCHEMBL18070 | 0.90 | ADRB2 (1.00) | ADRB2KDM4EMEN1TP53CYP3A4 | |
| Salmeterol SCHEMBL19211132 | 0.90 | ADRB2 (1.00) | ADRB2KDM4EMEN1TP53CYP3A4 | |
| Salmeterol SCHEMBL4767 | 0.89 | ADRB2 (1.00) | ADRB2KDM4EMEN1TP53CYP3A4 | |
| Salmeterol SCHEMBL29397921 | 0.89 | ADRB2 (1.00) | ADRB2KDM4EMEN1TP53CYP3A4 | |
| Salmeterol SCHEMBL29393289 | 0.89 | ADRB2 (1.00) | ADRB2KDM4EMEN1TP53CYP3A4 | |
| SCHEMBL4450046 | 0.89 | ADRB2 (1.00) | ADRB2KDM4EMEN1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2001881-A2 | COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY DISORDERS | Endacea, Inc. (US) | 2008-12-17 | — | — | EP | disclosed |
| US-20070219223-A1 | Compositions and methods for treating respiratory disorders | ENDACEA, INC. (US) | 2007-09-20 | — | — | US | disclosed |
| WO-2007103970-A2 | COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY DISORDERS | ENDACEA, INC. (US) | 2007-09-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219223-A1 | Compositions and methods for treating respiratory disorders | ADORA1, ADORA2A, ADORA2B | ADRB2 70/4885KDM4E 4261/4885MEN1 3905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.